X
Cancer Immunology, Immunotherapy (CII) is a scholarly journal dedicated to publishing research in the field of Biochemistry Genetics and Molecular Biology, and Published by Springer Nature. The Print-ISSN of Cancer Immunology, Immunotherapy is 03407004
The Publication fees (APC) is 3590 EUR; 4790 USD; 2990 GBP.
Cancer Immunology, Immunotherapy is published by Springer Nature, based in Germany, publishing since 2024. It covers research in Biochemistry Genetics and Molecular Biology, Immunology and Microbiology, Medicine.
Topics covered include oncology, cancer biology, tumor immunology.
The journal is indexed in Scopus, DOAJ; it uses a anonymous peer review process.
Article processing charge: 3590 EUR; 4790 USD; 2990 GBP.
For full aims and scope, see the journal's official page.
| Journal title | Cancer Immunology, Immunotherapy (CII) |
| Print ISSN | 03407004 |
| Online ISSN | 14320851 |
| Publisher Name | Springer Nature |
| Subject Category | Biochemistry Genetics and Molecular Biology |
| Access type | 🟢 Open Access |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Cancer Immunology, Immunotherapy
| Article Publication Charges (APC) |
3590 EUR; 4790 USD; 2990 GBP ✳️Without APC Biochemistry Genetics and Molecular Biology Journals |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
Add the app to your device for one-tap access.
